Member Info for oldsharedog

Each little nudge up is a little closer to BO territory - 0.60 and we are off and running :)

Bella - I love your enthusiasm but we have only had 2 small trades today ??

Don't shoot the messenger - i have a target of 3.5p here within a 3 month timeframe :)

GL - OSD

Thanks Plutuq - it;s just a bad situation made worse by the false dawns.

Judging from the weather here it is definitely the end of summer - the leaves on the aubergine plants have changed and Taverna's are already closing up and down the coast.

It has to prompt one question - is it time to invest my losses else where - 60% down and no immediate signs of additional communications due from the board.

The alternative is to lock the name QBT out of mindset and either have a nice surprise one day - as I have just had with IMM or wait to hear that they no longer exist - which ever it is it won't be any great shakes -we will still be able to go to the shops when I please and buy whatever we want :)

GLA.

OSD - contemplating the chop !!

A LITTLE BIT MORE CLARITY :

The NHS currently uses a combination of PSA blood tests and multiparametric MRI (mpMRI) scans for prostate cancer diagnosis, but has not adopted a single universal screening test.

FOR CLARITY :

Oxford BioDynamics (OBD) has collaborated with NHS hospitals, particularly through its clinical validation studies and partnerships involving its EpiSwitch® technology.

OBD’s work has intersected with NHS infrastructure in several ways:

• Clinical Validation in NHS Settings: OBD’s flagship EpiSwitch® platform—used for predictive blood tests in cancer and immunotherapy—has undergone clinical validation in UK hospital settings, including NHS-affiliated institutions. These studies help establish the utility of OBD’s tests in real-world clinical workflows.

• Prostate Screening Evaluation (PSE): OBD’s PSE test, designed to improve prostate cancer detection beyond standard PSA testing, has been evaluated in UK clinical environments. While specific NHS hospital names aren’t always disclosed publicly, the company has referenced UK-based trials and collaborations in its regulatory filings and press releases.

• Checkpoint Inhibitor Response Test: OBD’s immune checkpoint inhibitor response test has also been trialed in clinical cohorts that include NHS patients, particularly in oncology departments where such therapies are administered.

• Oxford Biomedical Research Centre (BRC): While not directly part of OBD, the NIHR Oxford BRC—hosted by Oxford University Hospitals NHS Foundation Trust—has a strong translational research pipeline. It’s plausible that OBD’s proximity and shared ecosystem with Oxford’s clinical research infrastructure has facilitated collaboration or data access.

I hope that the above is a clear synopsis of the situation here - there is a lot of misinformation on all boards - that try and divert attention - such as the political statement re pushing ppl to the front of the que ??? Why has that got any relevance or truth for that matter, especially considering recent events.

Please keep to the plot !!

Jiving - a well balanced and informative post

Thank you.

I recon there’s always 1 day where the SP suffers after a sustained rise. The fundamentals remain the same.

I think we will see the SP bounce back today into the .30 area - GLA

Not so much a miracle, but deserved.

An NHS contract would propel the SP way beyond that in a matter of days !!

And then there is the activity ongoing across the water.

Great product, great prospects, great anticipation !!!

Gluesniffer - you forgot to mention ODD, FDA etc etc

Now F.O.H. ( last word ) home 🙄

Ah - noted for their tall stories - that clears that one up 🤣🤣🤣💩

📈 Key Resistance Levels to Watch

• 0.65–0.70 GBp: This zone marks the next immediate resistance, where previous rallies have stalled.

• 0.90 GBp: A psychological level and former support turned resistance.

• 1.20 GBp: A breakout above here could signal a trend reversal toward the 2023 highs.

Obviously if a deal hits before then the above becomes irrelevant

I think news is near - when you consider the talk of month on month increases in the prostate testing side of the business, then when they release official figures and the trajectory that will outline, this will fly !!

! deal that's all - just 1 deal.

Kefalos coins has 2-1 against !!

Quick laugh.

I went to the doctors today and he told me i was impotent

So I rushed back home and put my best suit on

If i'm told i'm impotent - I'm going to look impotent.

Looks extremely positive too me - taken a small top up 100k ( shares not £s )

Every little helps - i can see this 4 x bagging quite easily quite quickly - Time will tell - I will give it a month or 2 !!

VikR/GG - welcome - almost home from home :)

I think this is going to be a great return - just need confirmation of a deal - if it gets done with NHS then WOW hold on to the roof cos it may blow off.

Same pattern as the last 3 days ( same as NFX ) PIs come in early with day traders - day traders sell - more PIs arrive and then the big trades start to be reported - and up she goes.

Steady & healthy - nice combination :)

FFX - Kalimera - I recon they may raise - although even if they do and the SP goes to .27 zone then it will be a matter of hors before it recovers.

I'm NOT concerned.

Exactly the same pattern as the last few days lots of PIs - then day traders come and go - then secured rise starts - then big money starts to be reported which could be increasing as we get nearer to news. BOOM TIME !!!

New boat put on hold - i will buy a rubber duck for the bath instead :(

All explained on the RNSs